Clinical Trials Logo

Clinical Trial Summary

Cerebral infarction by proximal occlusion of the anterior circulation is common with major personal and societal consequences. MRI is the gold standard for exploring stroke, especially ischemic, and a number of biomarkers on initial MRI (before reperfusion) are predictive of neurological prognosis. However, their spatiotemporal evolution in the suites of reperfusion is unclear. Close monitoring by MRI would make it possible to precisely know the tissue, vascular and microvascular evolution of the infarct area and the penumbra after reperfusion, and thus to characterize MRI biomarkers associated with efficient tissue reperfusion. The aim of the MR-Reperfusion study is to characterize new MRI biomarkers of efficient tissue reperfusion.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04952077
Study type Interventional
Source Central Hospital, Nancy, France
Contact Liang LIAO, MD
Phone +33383851618
Email l.liao@chru-nancy.fr
Status Recruiting
Phase N/A
Start date April 15, 2023
Completion date December 31, 2024